Skip to main content
Top
Published in: Abdominal Radiology 1/2006

01-02-2006

Bilateral giant adrenal myelolipomas

Authors: R. S. Kalidindi, L. Hattingh

Published in: Abdominal Radiology | Issue 1/2006

Login to get access

Abstract

Adrenal myelolipomas are rare benign tumors that comprise mature adipose cells and hematopoietic elements. They are usually found incidentally at autopsy and on imaging. Most cases are isolated and small. Although they are not hormonally active, there is very rarely an association with functional adrenal disorders such as Cushing syndrome and congenital adrenal hyperplasia. It is believed that in these patients high corticotropin levels contribute to the pathogenesis of these neoplasms. We report the imaging appearances of bilateral giant adrenal myelolipomas in a patient known to have congenital adrenal hyperplasia. To our knowledge, these are the largest bilateral adrenal myelolipomas reported in association with congential adrenal hyperplasia. A distinct change in their appearances after a period of steroid treatment is described for the first time.
Literature
1.
go back to reference Plaut A (1958) Myelolipoma in the adrenal cortex. Am J Pathol 34:487–515PubMed Plaut A (1958) Myelolipoma in the adrenal cortex. Am J Pathol 34:487–515PubMed
2.
go back to reference Kenney PJ, Wagner BJ, Rao P, Heffess CS (1998) Myelolipoma: CT and pathologic features. Radiology 208:87–95PubMed Kenney PJ, Wagner BJ, Rao P, Heffess CS (1998) Myelolipoma: CT and pathologic features. Radiology 208:87–95PubMed
3.
go back to reference Casey LR, Cohen AJ, Wile AG, Dietrich RB (1994) Giant adrenal myelolipomas: CT and MRI findings. Abdom Imaging 19:165–167PubMedCrossRef Casey LR, Cohen AJ, Wile AG, Dietrich RB (1994) Giant adrenal myelolipomas: CT and MRI findings. Abdom Imaging 19:165–167PubMedCrossRef
4.
go back to reference Umpierrez MB, Fackler S, Umpierrez GE, Rubin J. (1997) Adrenal myelolipoma associated with endocrine dysfunction: review of the literature. Am J Med Sci 314:338–341PubMedCrossRef Umpierrez MB, Fackler S, Umpierrez GE, Rubin J. (1997) Adrenal myelolipoma associated with endocrine dysfunction: review of the literature. Am J Med Sci 314:338–341PubMedCrossRef
5.
go back to reference Lockart ME, Smith JK, Kenney PJ (2002) Imaging of adrenal masses. Eur J Radiol 41:95–112CrossRef Lockart ME, Smith JK, Kenney PJ (2002) Imaging of adrenal masses. Eur J Radiol 41:95–112CrossRef
6.
go back to reference Nagase NL, Semelka RC, Armao D. (2002) Adrenal glands. In: Semelka RC, ed. Abdominal–pelvic MRI. New York: Wiley-Liss, pp 711–714 Nagase NL, Semelka RC, Armao D. (2002) Adrenal glands. In: Semelka RC, ed. Abdominal–pelvic MRI. New York: Wiley-Liss, pp 711–714
7.
go back to reference Selye H, Stone H (1950) Hormonally induced transformation of adrenal into myeloid tissue. Am J Pathol 26:211–233PubMed Selye H, Stone H (1950) Hormonally induced transformation of adrenal into myeloid tissue. Am J Pathol 26:211–233PubMed
8.
go back to reference Murakimi C, Ishibashi M, Kondo M, et al. (1992) Adrenal myelolipoma associated with congenital adrenal 21-hydroxylase deficiency. Intern Med 31:803–806CrossRef Murakimi C, Ishibashi M, Kondo M, et al. (1992) Adrenal myelolipoma associated with congenital adrenal 21-hydroxylase deficiency. Intern Med 31:803–806CrossRef
Metadata
Title
Bilateral giant adrenal myelolipomas
Authors
R. S. Kalidindi
L. Hattingh
Publication date
01-02-2006
Publisher
Springer-Verlag
Published in
Abdominal Radiology / Issue 1/2006
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-005-0014-4

Other articles of this Issue 1/2006

Abdominal Radiology 1/2006 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.